Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Biomater ; 171: 417-427, 2023 11.
Article in English | MEDLINE | ID: mdl-37696413

ABSTRACT

Biodegradable polymer-based therapeutics have recently become essential drug delivery biomaterials for various bioactive compounds. Biodegradable and biocompatible polymer-based biomaterials fulfill the requirements of these therapeutics because they enable to obtain polymer biomaterials with optimized blood circulation, pharmacokinetics, biodegradability, and renal excretion. Herein, we describe an adaptable polymerization platform employed for the synthesis of long-circulating, stimulus-sensitive and biodegradable biomaterials, therapeutics, or theranostics. Four chain transfer agents (CTA) were designed and successfully synthesized for the reversible addition-fragmentation chain transfer polymerization, allowing the straightforward synthesis of hydrolytically biodegradable structures of block copolymers-based biomaterials. The controlled polymerization using the CTAs enables controlling the half-life of the hydrolytic degradation of polymer precursors in a wide range from 5 h to 21 days. Moreover, the antitumor drug pirarubicin (THP) was successfully conjugated to the polymer biomaterials via a pH-sensitive hydrazone bond for in vitro and in vivo experiments. Polymer conjugates demonstrated superior antitumor efficacy compared to basic linear polymer-based conjugates. Notably, the biodegradable systems, even though those with degradation in the order of hours were selected, increased the half-life of THP in the bloodstream almost two-fold. Indeed, the presented platform design enables the main chain-end specific attachment of targeting ligands or diagnostic molecules. The adaptable polymerization platform design allows tuning of the biodegradability rate, stimuli-sensitive drug bonding, and optimized pharmacokinetics to increase the therapy outcome and system targeting, thus allowing the preparation of targeted or theranostic polymer conjugates. STATEMENT OF SIGNIFICANCE: Biodegradable and biocompatible polymer-based biomaterials are recognized as potential future bioactive nanomedicines. To advance the development of such biomaterials, we developed polymerization platforms utilizing tailored chain transfer agents allowing the straightforward synthesis of hydrolytically degradable polymer biomaterials with tuned biodegradability from hours to several days. The platform allows for the synthesis of long-circulating, stimulus-sensitive and biodegradable biomaterial serving as drug carriers or theranostics. The therapeutic potential was validated by preparation of polymer biomaterials containing pirarubicin, anticancer drug, bound via pH sensitive bond and by showing prolonged blood circulation and increased antitumor activity while keeping the drug side effects low. This work paves the way for future development of biodegradable polymer biomaterials with advanced properties in drug delivery.


Subject(s)
Antineoplastic Agents , Doxorubicin , Polymerization , Doxorubicin/chemistry , Antineoplastic Agents/therapeutic use , Drug Carriers/chemistry , Polymers/chemistry , Biocompatible Materials/pharmacology , Biocompatible Materials/chemistry
2.
Physiol Res ; 67(Suppl 2): S293-S303, 2018 10 30.
Article in English | MEDLINE | ID: mdl-30379551

ABSTRACT

In this review we summarize several synthetic approaches to the advanced synthesis of star-like polymer-based drug carriers. Moreover, their application as nanomedicines for therapy or the diagnosis of neoplastic diseases and their biodistribution are reviewed in detail. From a broad spectrum of star-like systems, we focus only on fully water-soluble systems, mainly based on poly(ethylene glycol) or N-(2-hydroxypropyl)methacrylamide polymer and copolymer arms and polyamidoamine dendrimers serving as the core of the star-like systems.


Subject(s)
Drug Carriers/chemistry , Drug Carriers/metabolism , Polymers/chemistry , Polymers/metabolism , Animals , Drug Carriers/administration & dosage , Humans , Methacrylates/administration & dosage , Methacrylates/chemistry , Methacrylates/metabolism , Polyethylene Glycols/administration & dosage , Polyethylene Glycols/metabolism , Polymers/administration & dosage , Tissue Distribution/drug effects , Tissue Distribution/physiology
3.
Physiol Res ; 67(Suppl 2): S357-S365, 2018 10 30.
Article in English | MEDLINE | ID: mdl-30379556

ABSTRACT

Novel star polymers based on the water-soluble N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer and cyclodextrin were synthesized and the physico-chemical behavior of these precursors was studied. Semitelechelic HPMA copolymers were grafted onto the cyclodextrin core, thus forming star-like structure. Both prepared systems were designed as possible polymer carriers for the controlled release of cytostatic drugs, which after the drug release and degradation will be eliminated from the organism. Two synthesis approaches were used to obtain similar polymer carriers with different degradation rates. All the polymers were prepared by reversible addition-fragmentation chain-transfer polymerization, which guarantees low dispersity of the prepared systems.


Subject(s)
Chemistry, Pharmaceutical/methods , Cyclodextrins/chemical synthesis , Polymers/chemical synthesis , Water/chemistry , Cyclodextrins/metabolism , Methacrylates/chemical synthesis , Methacrylates/metabolism , Polymers/metabolism , Solubility , Water/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...